INOSITEC
Inositec is a biotech company that develops a treatment for soft tissue calcification disorders based on its proprietary Inositune platform of inositol phosphate (IP6) analogs. Its lead programs address vascular and renal calcification disorders, including orphan indications. The company was founded in 2015 as a spin-off of ETH Zurich.
INOSITEC
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2015-12-01
Address:
Zürich, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.inositec.com
Total Employee:
1+
Status:
Active
Contact:
+41442710755
Email Addresses:
[email protected]
Total Funding:
1.41 M CHF
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Analytics WordPress Content Delivery Network Google Universal Analytics Apache Wordpress Plugins Sitelinks Search Box
Similar Organizations
NMD Pharma
NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.
Current Advisors List
Current Employees Featured
Founder
Investors List
Zürcher Kantonal Bank
Zürcher Kantonal Bank investment in Seed Round - Inositec
VI Partners
VI Partners investment in Seed Round - Inositec
Venture Kick
Venture Kick investment in Grant - Inositec
Official Site Inspections
http://www.inositec.com
- Host name: ip-173-201-182-241.ip.secureserver.net
- IP address: 173.201.182.241
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Inositec"
Inositec - Crunchbase Company Profile & Funding
Inositec is a biotech company that develops a treatment for soft tissue calcification disorders based on its proprietary Inositune platform of inositol …See details»
Inositec Company Profile 2024: Valuation, Investors
Inositec General Information Description. Operator of a research and development company intended to offer treatments for soft tissue calcification …See details»
Inositec AG - VentureRadar
Inositec is building a pipeline of first-in-class drugs based on inositol phosphate (IP6), with lead …See details»
Inositec AG - Zürich, Switzerland - bionity.com
The lead compound INS-3001 is a cardiovascular calcification inhibitor in development for …See details»
Inositec - Products, Competitors, Financials, Employees, …
This year the organization has offered an interest free loan of CHF 100’000 to each of the two …See details»
Inositec - Ownership and Business Overview - Mergr
Nov 22, 2021 Inositec’s novel asset INS-3001, is a once-daily subcutaneous treatment for …See details»
Inositec - Company Profile - Tracxn
Nov 1, 2024 Inositec - Developer of therapeutics for soft tissue calcification disorders. Raised …See details»
Inositec - Overview, News & Similar companies | ZoomInfo.com
Nov 21, 2021 Who is Inositec. Inositec is pioneering the development of life-saving small …See details»
Inositec AG - Drug pipelines, Patents, Clinical trials - Synapse
Explore Inositec AG with its drug pipeline, therapeutic area, technology platform, 1 news, …See details»
Inositec Company Profile - Office Locations, Competitors ... - Craft
Inositec is a company developing treatments for soft tissue calcification disorders. It develops …See details»
Inositec AG - Venture Kick
Inositec was founded in December 2015 based on the award-winning research of Dr. Mattias Ivarsson, Prof. Jean-Christophe Leroux and Prof. Bastien Castagner at ETH Zurich, Switzerland. ... ORGANIZATION. Transforming scientific …See details»
Inositec | Biotech Careers
Inositec AG is a biotech spin-off from ETH Zurich founded in December 2015 to develop …See details»
Inositec AG - startup.ch
Inositec is pioneering the development of life-saving small molecule drugs based on inositol …See details»
Vifor Pharma acquires Inositec - 2021-11-22 - Crunchbase
Nov 22, 2021 Inositec Inositec is a biotech company that develops a treatment for soft tissue …See details»
Inositec - Contacts, Employees, Board Members, Advisors & Alumni
Inositec is a biotech company that develops a treatment for soft tissue calcification disorders.See details»
Inositec AG - Venturelab
Dec 21, 2015 Inositec is pioneering the development of life-saving small molecule drugs …See details»
Inositec gets acquired by Vifor Pharma to advance the vascular ...
Nov 22, 2021 Vifor Pharma has announced the acquisition of two companies: Swiss-based …See details»
Inositec - VI Partners
Inositec is pioneering the development of life-saving small molecule drugs based on inositol …See details»
Mattias Ivarsson - CEO and founder @ Inositec - Crunchbase
Primary Organization . Inositec . Location Zürich, Zurich, Switzerland; Regions Europe, Middle …See details»
INS-6015 - Drug Targets, Indications, Patents - Synapse
INS-6015, Initially developed by Inositec AG, Now, its global highest R&D status is Preclinical, …See details»